ENHYPEN singer Jay has tested positive for COVID-19, and will be halting his activities with the group for the time being.On July 21, music label Belift Lab published a statement to South Korean outlet Mydaily announcing that the Korean-American idol has been diagnosed with COVID-19 after positive results on both a rapid antigen test and a PCR test on the same day.“He is currently showing symptoms like mild sore throat and body aches and is being treated at home away from the other members,” Belift Lab’s statement read, as translated by Soompi.
The label then added that all remaining members of ENHYPEN tested negative on self-testing kits after Jay’s diagnosis.“As such, Jay will not be able to participate in ENHYPEN’s schedule for the time being.
We will continue to provide an update on when he will resume activities,” wrote Belift Lab. “Our company will place the artists’ health as our top priority, and we will do everything we can to aid Jay in his speedy recovery.
We will also diligently cooperate with the requests and guidelines of healthcare authorities.”The news of Jay’s diagnosis and halt in scheduled activities comes on the heels of the group’s announcement today (July 21) of venue and ticketing details for the US leg of their upcoming ‘Manifesto’ world tour.
Read more on nme.com
Get the latest stars news and celebrity rumours with exclusive stories, photos, videos and interviews.
Breaking up, scandals, engagements, divorces, gossip – all you need to know about the private lives of your favorite celebs.
Get to know the latest showbiz news along with exclusive interviews and even more. All this is waiting for you on the main page 24 hours a day, 7 days a week! Who, where, when, with whom, how, why and for what!? Stay tuned to know first!
Just follow us daily and we will provide you with the current news from the life of famous stars and celebrities.
Owner: SNOWLAND s.r.o.
Registration certificate 06691200
Address:
Snowland s.r.o.
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6
Czech Republic
©2024. All rights reserved.